Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · IEX Real-Time Price · USD
43.17
+1.38 (3.29%)
Mar 28, 2024, 3:11 PM EDT - Market open

Rhythm Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
60.41128.0159.58101.2662.749.9434.466.7735.09
Short-Term Investments
215.77205.61235.6171.94230.17202.52113.8540
Cash & Cash Equivalents
276.17333.62295.18173.2292.86252.46148.3110.7635.09
Cash Growth
-17.22%13.02%70.43%-40.86%16.00%70.23%1278.06%-69.33%-
Receivables
14.876.221.03000000.06
Inventory
8.622.920.11000000
Other Current Assets
8.611.4812.078.479.546.232.360.410.34
Total Current Assets
308.27354.24308.39181.67302.4258.69150.6711.1835.49
Property, Plant & Equipment
2.123.384.3455.721.120.840.930.02
Goodwill and Intangibles
7.037.884.66000000
Other Long-Term Assets
15.3316.9812.140.40.40.40.230.231.77
Total Long-Term Assets
24.4828.2521.145.416.121.521.071.161.78
Total Assets
332.75382.48329.52187.07308.52260.21151.7412.3437.28
Accounts Payable
4.894.85.744.910.427.642.4322.06
Deferred Revenue
1.291.437000000.25
Current Debt
0.770.680.610.540.470000
Other Current Liabilities
48.2632.8930.0812.5613.535.944.292.732.96
Total Current Liabilities
55.239.8143.4317.9924.4213.586.724.735.27
Long-Term Debt
0.491.261.952.553.090000
Other Long-Term Liabilities
107.2977.150000.370.230.310
Total Long-Term Liabilities
107.7878.411.952.553.090.370.230.310
Total Liabilities
162.99118.2245.3720.5527.513.956.955.045.27
Total Debt
1.261.942.553.093.560000
Debt Growth
-35.19%-23.79%-17.34%-13.27%-----
Retained Earnings
-894.74-710.06-528.94-459.33-325.33-184.6-110.25-76.54-50.67
Comprehensive Income
0.13-0.09-00.0500000
Shareholders' Equity
169.76264.26284.15166.53281.02246.26144.79-32.7-8
Net Cash / Debt
274.91331.67292.63170.11289.3252.46148.3110.7635.09
Net Cash / Debt Growth
-17.11%13.34%72.03%-41.20%14.59%70.23%1278.06%-69.33%-
Net Cash Per Share
4.776.365.903.857.948.1411.181.063.44
Working Capital
253.07314.43264.96163.67277.99245.11143.956.4430.22
Book Value Per Share
2.945.075.733.777.727.9410.91-3.21-0.79
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).